BEIJING, Aug. 17, 2026 (GLOBE NEWSWIRE) — Baosheng Media Group Holdings Limited (NASDAQ: BAOS) (“Baosheng” or the “Company”) today announced that it has entered into a strategic acquisition memorandum of understanding with Blue Intelligence Cloud Innovation Technology (Beijing) Co., Ltd. (“Blue Intelligence Cloud Innovation Technology”). Under the proposed transaction, Baosheng intends to acquire a 40% equity interest in Blue Intelligence Cloud Innovation Technology. If successfully completed, the strategic investment is expected to provide Baosheng with access to robust AI-powered capabilities, including AI intelligent marketing, intelligent content generation, user data analytics, and AI-enabled operations. The two parties plan to establish synergies around AI-driven traffic acquisition, user insights, precision engagement, marketing...

TORONTO, Aug. 17, 2026 (GLOBE NEWSWIRE) — Volaris Group today announced the acquisition of Alertacall, a UK-based provider of customer engagement and communications technology for the social housing and retirement living sectors. Alertacall delivers a purpose-built combination of Software as a Service (SaaS) software, dedicated hardware, and a UK-based contact center, enabling housing providers to meet their regulatory obligations and improve contact with older and vulnerable customers. “After more than 21 years of growing Alertacall – which started with my invention of the ‘I’m okay button’ for my grandmother Eveline – we are all incredibly proud to have built something that delivers such an amazing impact for so many people,” said Alertacall founder and CEO James Batchelor MBE. “But with such huge opportunities...

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. As outlined in Company Announcement no. 48 of 14 August 2026, the programme was extended with up to DKK 170 million, increasing the total amount of which Schouw & Co. will acquire shares to up to DKK 410 million. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 7 August 2026 242,183 646.46 156,560,665    Monday,...

Combined company to operate as Slate Medicines and focus on advancing Slate’s portfolio of next-generation migraine therapeutics Slate’s lead product candidate, SLTE-1009, is a clinical stage, potentially best-in-class subcutaneous anti-PACAP/VIP monoclonal antibody for the preventative treatment of migraine Concurrent oversubscribed private placement financing of $245 million from a leading syndicate of healthcare investors anticipated to fund operations into 2029 Companies to hold conference call on August 17, 2026, at 8:00 a.m. ET CAMBRIDGE, Mass. and RALEIGH, N.C., Aug. 17, 2026 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (“Fulcrum”) (Nasdaq: FULC) and Slate Medicines, Inc. (“Slate”), a biotechnology company developing next-generation therapeutics for the treatment of migraine, announced today that they have entered...

A.P. Moller Capital – Emerging Markets Infrastructure Fund II and APM Capital Morocco Fund to acquire majority stake in Globex, establishing a partnership with Founder and CEO Omar El Kadiri, who will remain in place along with an experienced management team Strong alignment with A.P. Moller Capital’s geographic and sector focus in Morocco and in transportation and logistics Globex is underpinned by exclusive local market licensing agreements, with established market positions in express delivery, road freight, freight forwarding and customs brokerageCOPENHAGEN, Denmark and CASABLANCA, Morocco, Aug. 17, 2026 (GLOBE NEWSWIRE) — A.P. Moller Capital is pleased to announce that A.P. Moller Capital – Emerging Markets Infrastructure Fund II (“EMIF II”) and APM Capital Morocco Fund (together “the Funds”) have signed an agreement...

Following Nine Months of Avoiding Engagement, Genco Board Demands Consideration Valued at Approximately $36.91 Per Share — a 57% Premium to Genco’s Undisturbed Share Price at the Time of Diana’s Last Offer Genco’s Demands Are Completely Disconnected from the Reality of What a Credible Buyer Could Reasonably Be Expected to Pay Shareholders Should Question Whose Interests Their Board Is Actually Serving By Making Demands That Can’t Possibly Be Met, Shareholders are Effectively Being Prevented from Realizing an Attractive Premium, As Board Makes its Misalignment with Shareholders and Primary Focus on its Personal Interests Crystal Clear Diana Remains Genco’s Largest Shareholder and Will Continue to Raise These Issues and Hold the Board Accountable for Every Commitment It Has Made. ATHENS, Greece, Aug. 14, 2026 (GLOBE NEWSWIRE) —...

Independent certification from global human health organization NSF demonstrates a commitment to personal care product quality and compliance with U.S. GMP requirementsDr Christina Rahm / Strata Biotech LabDr. Christina Rahm, Founder of Strata Biotech Labs, at the company’s NSF/ANSI 455-2 GMP-certified manufacturing facility in Las Vegas, Nevada.Las Vegas, Nevada, Aug. 14, 2026 (GLOBE NEWSWIRE) — Strata Biotech Labs, LLC’s manufacturing facility in Las Vegas, Nevada, was recently added to NSF’s NSF/ANSI 455-2 Dietary Supplements Good Manufacturing Practice (GMP) certification. Earning GMP certification from NSF verifies that a manufacturing facility has the proper methods, equipment, facilities and controls in place to produce dietary supplement products. Strata Biotech Labs’ facility at 6320 McLeod Drive, Suite 1, Las...

MONTREAL, Aug. 14, 2026 (GLOBE NEWSWIRE) — Boralex Inc. (“Boralex” or the “Corporation“) (TSX: BLX), Brookfield and La Caisse (formerly CDPQ) announced today the completion of the previously announced acquisition of Boralex by Brookfield, together with its institutional partners including Brookfield Renewable Partners, and La Caisse (the “Purchaser“), by way of a plan of arrangement under the provisions of the Canada Business Corporations Act (the “Arrangement“). Pursuant to the terms of the Arrangement, the Purchaser acquired all of the issued and outstanding class A common shares (the “Shares“) of Boralex for a price of $37.25 per Share in cash. The Purchaser has caused to be delivered to Computershare Investor Services Inc. (“Computershare“), the depositary...

Private Funding of US$70 Million Secured and Completion Targeted for 30 October 2026 LONDON, Aug. 14, 2026 (GLOBE NEWSWIRE) — Diginex Limited (NASDAQ: DGNX) (“Diginex” or the “Company”), a provider of ESG, sustainability and compliance solutions to institutional and corporate clients, today announced the signing of an amended and restated sale and purchase agreement (the “A&R SPA”) relating to Diginex’s proposed acquisition of Resulticks Global Companies Pte. Limited (“Resulticks”), the Singapore-headquartered global provider of AI-powered, real-time customer engagement solutions, serving some of the world’s largest Fortune 1,000 brands. Resulticks generated US$150 million in revenue and US$17 million in profit after tax for FY2025, while achieving a compound annual growth rate (CAGR) in excess of 60% since the pandemic....

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree GOOCH & HOUSEGO PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...